Što znači "Očistiti"?
Životinja ne nosi mutaciju. Neće razviti bolest i neće ga prenijeti.
Discover the importance of the DNA test for Congenital Myasthenic Syndrome (CMS) in cats, a genetic disorder affecting muscle function. Early detection through this specialized DNA test helps breeders and cat owners identify carriers and affected cats, ensuring responsible breeding practices. CMS can cause muscle weakness and fatigue, impacting a cat’s quality of life. By using the CMS DNA test, you can prevent the spread of this inherited condition and promote healthier feline generations. Trust reliable veterinary genetic testing labs for accurate and fast results. Protect your cat’s health with the Congenital Myasthenic Syndrome DNA test today. Stay informed and keep your feline companion strong and active!
Congenital Myasthenic Syndrome (CMS) in cats is a rare genetic disorder affecting the communication between nerves and muscles. A DNA test can identify mutations responsible for CMS, helping veterinarians confirm the diagnosis. Early detection through genetic testing allows for better management and treatment options. Breeders can use DNA testing to avoid passing the condition to offspring. Overall, the test plays a crucial role in improving the health and quality of life for affected cats.
Ovaj DNK test je uključen počevši od našeg paketa Basic — i također je dio paketa Basic, Standard, Advanced, Complete.
Pogledajte pakete DNK testova →Congenital Myasthenic Syndrome (CMS) is a rare neuromuscular disorder found in cats that affects the communication between nerves and muscles. This condition is characterized by a defect in the transmission of signals at the neuromuscular junction, leading to muscle weakness and fatigue. Cats with CMS may exhibit symptoms such as difficulty in walking, muscle tremors, and exercise intolerance. The severity of these symptoms can vary significantly among affected individuals.
CMS is primarily caused by genetic mutations that affect proteins involved in the neuromuscular transmission process. These mutations can impact various components, including acetylcholine receptors or associated proteins, which are crucial for muscle contraction. The genetic nature of CMS means that affected cats typically inherit the condition from their parents, although new mutations can also arise. By identifying the specific genetic mutation responsible for CMS, veterinarians can provide more accurate diagnoses and tailor treatment plans for affected cats.
The clinical presentation of CMS in cats can vary, but common signs include progressive muscle weakness, particularly after exertion. Affected cats may also show signs of lethargy, decreased activity levels, and difficulty swallowing or chewing. In some cases, symptoms may not be apparent until the cat is older, making early diagnosis challenging. Monitoring for these symptoms is crucial for timely intervention and management of the disease.
Diagnosing CMS involves a combination of clinical evaluation and genetic testing. DNA testing plays a vital role in confirming the presence of genetic mutations associated with CMS. This test not only aids in diagnosing affected cats but also assists in identifying carriers, which can be important for breeding decisions. Early diagnosis through DNA testing can lead to better management strategies and improve the quality of life for affected animals.
While there is currently no cure for CMS, management strategies focus on alleviating symptoms and improving the cat's quality of life. Treatment options may include medications that enhance neuromuscular transmission, physical therapy to maintain muscle strength, and supportive care to manage symptoms. Regular veterinary check-ups are essential to monitor the progression of the disease and adjust treatments as necessary. The involvement of a veterinarian familiar with CMS can provide the best outcomes for affected cats.
Congenital Myasthenic Syndrome is a significant condition in cats that requires careful consideration and management. Understanding the genetic basis, clinical signs, and available treatments is crucial for pet owners and veterinarians alike. DNA testing offers valuable insights into the condition, aiding in diagnosis and management strategies that can enhance the well-being of affected cats.
Životinja ne nosi mutaciju. Neće razviti bolest i neće ga prenijeti.
Ne. Životinja je općenito zdrava, ali može prenijeti mutaciju na svoju potomstvo.
Nosi dvije mutirane kopije. Klinički znakovi se očekuju ovisno o bolest. Ne treba ga uzgajati.
Neke bolesti su spolno povezane, pa njihov izraz varira ovisno o spol životinje.
This DNA test detects the mutation associated with Congenital Myasthenic Syndrome (CMS) in order to identify clear, carrier, or at-risk animals.
DNK testiranje pomaže uzgajivačima u planiranju sigurnijih parenja i smanjenju rizika od prijenosa mutacije na potomstvo.
Način nasljeđivanja prijavljen za ovaj test je autosomno recesivan.
This test analyses the mutation COLQ c.1190G>A.
Nije nužno. Tumačenje ovisi o obrascu nasljeđivanja i rezultirajućem genotipu.
Abitbol Marie, Hitte Christophe, Bossé Philippe, BlanchardGutton Nicolas, Thomas Anne, Martignat Lionel, Blot Stéphane, Tiret Laurent. A COLQ Missense Mutation in Sphynx and Devon Rex Cats with Congenital Myasthenic Syndrome. PLoS One. 2015 Sep 1;10(9):e0137019. doi: 10.1371/journal.pone.0137019. eCollection 2015.
Vaša privatnost, vaš izbor
Koristimo bitne kolačiće za rad web stranice. Neobavezni kolačići (kao što su ugrađeni davatelji sadržaja) onemogućeni su prema zadanim postavkama i omogućeni su samo ako se slažete. Svoj odabir možete promijeniti bilo kada pomoću gumba "Kolačići".
Potrebno za osnovne značajke i sigurnost. Uvijek omogućeno.
Poboljšava značajke poput spremanja postavki ili ugrađivanja bez oglašavanja.
Pomaže nam razumjeti korištenje stranice. Onemogućeno prema zadanim postavkama.
Oglašavanje/praćenje na web-lokacijama (ugrađeni neki videozapisi/karte). Onemogućeno prema zadanim postavkama.